Physician

Helen L Slone, M.D.

According to 2025 Medicare claims, Helen Slone, M.D. (NPI: 1285639732) practices endocrinology in the Vineland, NJ market, with the plurality of this provider's patient population coming from Cumberland, NJ. Slone uses personal NPI as billing NPI and primary practice location at 08360-7056.

Slone's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 926 traditional Medicare patients, billed 4,067 HCPCS/CPT codes, and received $320,518 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 10,513 prescription claims across 1,291 beneficiaries totaling $4,993,503 in drug costs, led by Jardiance (Empagliflozin). DME data shows 903 claims. Open Payments data shows 120 records totaling $2,004. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $539,074 and ending at $320,518. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,405,933 to $4,993,503. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $36,412 to $210,938.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,723	8,561	$539,074
2016	1,634	7,305	$444,626
2017	1,407	6,473	$379,365
2018	1,279	5,345	$312,742
2019	1,165	4,955	$299,210
2020	1,098	4,735	$337,936
2021	1,072	5,475	$463,250
2022	1,011	4,425	$368,161
2023	1,014	4,517	$385,716
2024	926	4,067	$320,518

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	976	7,253	$2,405,933
2016	947	7,188	$2,626,246
2017	922	6,982	$2,675,776
2018	1,007	7,290	$2,866,219
2019	1,039	7,611	$3,021,681
2020	1,058	8,092	$3,232,494
2021	1,118	8,601	$3,930,432
2022	1,208	9,040	$4,894,777
2023	1,288	9,731	$5,815,084
2024	1,291	10,513	$4,993,503

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,068	2,387	$81,568
2016	1,136	2,346	$83,198
2017	654	1,368	$45,441
2018	622	1,470	$42,541
2019	560	1,438	$80,159
2020	515	1,366	$112,154
2021	432	1,387	$159,250
2022	343	1,325	$177,451
2023	333	1,351	$200,736
2024	292	903	$222,603

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	98	98	$126
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	226	261	$99
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	688	1,779	$94
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	231	1,924	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	962	65,490	$1,245,639
Mounjaro	Tirzepatide	911	29,157	$1,059,461
Trulicity	Dulaglutide	277	15,276	$489,977
Farxiga	Dapagliflozin Propanediol	345	23,034	$418,449
Ozempic	Semaglutide	103	5,030	$159,560

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	89	368	$176,922
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	11	33	$11,688
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	14	45	$10,183
E0784	External ambulatory infusion pump, insulin	Y	N/R	17	$5,891
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$4,846

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	120	$2,004	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Helen L. Slone, M.D.?

Tedicare shows public-source Medicare data for Helen L. Slone, M.D. (NPI 1285639732), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Helen L. Slone, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Helen L. Slone, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Helen L. Slone, M.D. have Open Payments data?

Helen L. Slone, M.D. has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.